Literature DB >> 8329398

The high-resolution, three-dimensional solution structure of human interleukin-4 determined by multidimensional heteronuclear magnetic resonance spectroscopy.

R Powers1, D S Garrett, C J March, E A Frieden, A M Gronenborn, G M Clore.   

Abstract

The high-resolution three-dimensional solution structure of recombinant human interleukin-4 (IL-4), a protein of approximately 15 kDa which plays a key role in the regulation of B and T lymphocytes, has been determined using three- and four-dimensional heteronuclear NMR spectroscopy. The structure is based on a total of 2973 experimental NMR restraints, comprising 2515 approximate interproton distance restraints, 102 distance restraints for 51 backbone hydrogen bonds, and 356 torsion angle restraints. A total of 30 structures was calculated by means of hybrid distance geometry-simulated annealing, and the atomic rms distribution about the mean coordinate positions for residues 8-129 is 0.44 +/- 0.03 A for the backbone atoms, 0.83 +/- 0.03 A for all atoms, and 0.51 +/- 0.04 A for all atoms excluding disordered side chains. The N- and C-terminal residues (1-7 and 130-133, respectively) appear to be disordered. The structure of IL-4 is dominated by a left-handed four-helix bundle with an unusual topology comprising two overhand connections. The linker elements between the helices are formed by either long loops, small helical turns, or short strands. The latter include a mini anti-parallel beta-sheet. A best fit superposition of the NMR structure of IL-4 with the 2.25 A resolution crystal structure [Wlodawer, A., Pavlovsky, A., & Gutschina, A. (1992) FEBS Lett. 309, 59-64] yields a backbone atomic rms difference of 1.37 A which can be mainly attributed to tighter packing of the helices in the crystal structure. This is indicated by an approximately 20% reduction in the axial separation of three pairs of helices (alpha A-alpha C, alpha A-alpha D, and alpha C-alpha D) in the crystal structure relative to the NMR structure and may reflect the greater flexibility of the molecule in solution which is reduced in the crystal due to intermolecular contacts. Comparison of the NMR structure of IL-4 with the X-ray structures of two other related proteins, granulocyte-macrophage colony stimulating factor [Diedrichs, K., Boone, T., & Karplus, P. A. (1992) Science 254, 1779-1782] and human growth hormone [de Vos, A. M., Ultsch, M., & Kossiakoff, A. A. (1992) Science 255, 306-312], that bind to the same hematopoietic superfamily of cell surface receptors reveals a remarkably similar topological fold, despite the absence of any significant overall sequence identity, and substantial differences in the relative lengths of the helices, the lengths and the nature of the various connecting elements, and the pattern and number of disulfide bridges.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8329398     DOI: 10.1021/bi00077a030

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  32 in total

1.  Arm-site binding by lambda -integrase: solution structure and functional characterization of its amino-terminal domain.

Authors:  Jonathan M Wojciak; Dibyendu Sarkar; Arthur Landy; Robert T Clubb
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-19       Impact factor: 11.205

2.  The three-dimensional solution structure of the SRC homology domain-2 of the growth factor receptor-bound protein-2.

Authors:  M M Senior; A F Frederick; S Black; N J Murgolo; L M Perkins; O Wilson; M E Snow; Y S Wang
Journal:  J Biomol NMR       Date:  1998-02       Impact factor: 2.835

3.  Enthalpic and entropic contributions mediate the role of disulfide bonds on the conformational stability of interleukin-4.

Authors:  Daniela C Vaz; J Rui Rodrigues; Walter Sebald; Christopher M Dobson; Rui M M Brito
Journal:  Protein Sci       Date:  2006-01       Impact factor: 6.725

4.  Solution structure of an ABC collagen heterotrimer reveals a single-register helix stabilized by electrostatic interactions.

Authors:  Jorge A Fallas; Varun Gauba; Jeffrey D Hartgerink
Journal:  J Biol Chem       Date:  2009-07-22       Impact factor: 5.157

5.  (1)H, (13)C and (15)N NMR backbone assignments of the 269-residue serine protease PB92 from Bacillus alcalophilus.

Authors:  R H Fogh; D Schipper; R Boelens; R Kaptein
Journal:  J Biomol NMR       Date:  1994-01       Impact factor: 2.835

6.  Automated error-tolerant macromolecular structure determination from multidimensional nuclear Overhauser enhancement spectra and chemical shift assignments: improved robustness and performance of the PASD algorithm.

Authors:  John J Kuszewski; Robin Augustine Thottungal; G Marius Clore; Charles D Schwieters
Journal:  J Biomol NMR       Date:  2008-07-31       Impact factor: 2.835

7.  Comprehensive clarification of two paralogous interleukin 4/13 loci in teleost fish.

Authors:  Maki Ohtani; Nobuhiro Hayashi; Keiichiro Hashimoto; Teruyuki Nakanishi; Johannes Martinus Dijkstra
Journal:  Immunogenetics       Date:  2008-06-17       Impact factor: 2.846

8.  Hematopoietic cytokines: similarities and differences in the structures, with implications for receptor binding.

Authors:  A Wlodawer; A Pavlovsky; A Gustchina
Journal:  Protein Sci       Date:  1993-09       Impact factor: 6.725

9.  Structure of the Bacillus anthracis Sortase A Enzyme Bound to Its Sorting Signal: A FLEXIBLE AMINO-TERMINAL APPENDAGE MODULATES SUBSTRATE ACCESS.

Authors:  Albert H Chan; Sung Wook Yi; Austen L Terwilliger; Anthony W Maresso; Michael E Jung; Robert T Clubb
Journal:  J Biol Chem       Date:  2015-08-31       Impact factor: 5.157

10.  Structural basis for the sequence-specific RNA-recognition mechanism of human CUG-BP1 RRM3.

Authors:  Kengo Tsuda; Kanako Kuwasako; Mari Takahashi; Tatsuhiko Someya; Makoto Inoue; Takaho Terada; Naohiro Kobayashi; Mikako Shirouzu; Takanori Kigawa; Akiko Tanaka; Sumio Sugano; Peter Güntert; Yutaka Muto; Shigeyuki Yokoyama
Journal:  Nucleic Acids Res       Date:  2009-06-24       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.